Tavaborole
Active ingredient: Tavaborole
In short: Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
What is Tavaborole used for?
Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Tavaborole dosage
Apply tavaborole topical solution to affected toenails once daily for 48 weeks.
Tavaborole topical solution should be applied to the entire toenail surface and under the tip of each toenail being treated.
Tavaborole topical solution is for topical use only and not for oral, ophthalmic, or intravaginal use.
How to take Tavaborole — instructions & advice from the label
See FDA-approved patient labeling (Patient Information and Instructions for Use)
The patient should be told the following:
The impact of nail polish or other cosmetic nail products on the efficacy of tavaborole topical solution has not been evaluated.
Inform a health care professional if the area of application shows signs of persistent irritation (for example, redness, itching, swelling).
Product is flammable. Avoid use near heat or open flame.
Manufactured by:
Alembic Pharmaceuticals Limited
(Derma Division),
Karakhadi, Vadodara 391450, India.
Mfg. License No.: G/25/2216
PATIENT INFORMATION
Tavaborole (ta'' va bor' ole) topical solution, 5%
Important information: Tavaborole topical solution is for use on toenails only. Do not use tavaborole topical solution in your mouth, eyes, or vagina.
What is tavaborole topical solution?
Tavaborole topical solution is a prescription medicine used to treat fungal infections of the toenails. It is not known if tavaborole topical solution is safe and effective in children less than 6 years age. …
Warnings & precautions
Do not take this medicine if: None.
Tavaborole side effects
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
In two clinical trials, 791 subjects were treated with tavaborole topical solution. The most commonly reported adverse reactions are listed below (Table 1).
Preferred Term | Tavaborole Topical Solution
N=791
n(%) | Vehicle
N=395
n(%)
Application site exfoliation | 21 (2.7%) | 1 (0.3%)
Ingrown toenail | 20 (2.5%) | 1 (0.3%)
Application site erythema | 13 (1.6%) | 0 (0%)
Application site dermatitis | 10 (1.3%) | 0 (0%)
The following adverse reactions have been identified during postmarketing use of tavaborole topical solution. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug product exposure:
Hypersensitivity; contact allergy
About this medicine
Tavaborole topical solution, 5% contains tavaborole, 5% (w/w) in a clear, colorless alcohol-based solution for topical use. The active ingredient, tavaborole, is an oxaborole antifungal with the chemical name of 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole. The chemical formula is C7H6BFO2, the molecular weight is 151.93 and the structural formula is:
Tavaborole is a white to off-white powder. It is slightly soluble in water and freely soluble in ethanol and propylene glycol.
Each mL of tavaborole topical solution contains 43.5 mg of tavaborole. Inactive ingredients include alcohol (73.11% v/v), edetate calcium disodium, and propylene glycol.
How it works: Tavaborole topical solution is an oxaborole antifungal . At therapeutic doses, tavaborole topical solution is not expected to prolong QTc to any clinically relevant extent. Tavaborole undergoes extensive metabolism.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 6da415c6-a9be-42bf-829f-e72ccc5fe3ba. Read the full official label on DailyMed.
Related medicines
Amoxicillin Azithromycin Doxycycline Amoxicillin and Clavulanate Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin